Skip to main content

Ipratropium nasal Pregnancy and Breastfeeding Warnings

Brand names: Atrovent Nasal

Medically reviewed by Drugs.com. Last updated on Aug 10, 2023.

Ipratropium nasal Pregnancy Warnings

Use is recommended only if clearly needed and the benefit outweighs the risk.

US FDA pregnancy category: B

Animal studies have failed to reveal evidence of teratogenicity or embryotoxicity at higher doses. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Ipratropium nasal Breastfeeding Warnings

According to some authorities, use of this drug produces negligible maternal serum levels and any drug in breast milk would not be absorbed by the infant.

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: Some of this drug is systemically absorbed following nasal administration, however, the amount which may be excreted in human milk is unknown.

See references

References for pregnancy information

  1. Product Information. Atrovent Nasal (ipratropium nasal). Boehringer-Ingelheim.
  2. Cerner Multum, Inc. UK Summary of Product Characteristics.
  3. Product Information. Ipratropium Bromide Nasal (ipratropium nasal). West-Ward Pharmaceuticals Corporation (previously Roxane Laboratories Inc). 2017.

References for breastfeeding information

  1. Product Information. Atrovent Nasal (ipratropium nasal). Boehringer-Ingelheim.
  2. Cerner Multum, Inc. UK Summary of Product Characteristics.
  3. United States National Library of Medicine. Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT 2013.
  4. Product Information. Ipratropium Bromide Nasal (ipratropium nasal). West-Ward Pharmaceuticals Corporation (previously Roxane Laboratories Inc). 2017.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.